期刊文献+

日本血吸虫双价DNA疫苗对小鼠单次肌肉注射的毒性试验 被引量:1

Acute toxicity test of Schistosoma japonicum bivalent DNA vaccine with single dosage in mice
下载PDF
导出
摘要 目的观察日本血吸虫双价DNA疫苗单次肌肉注射小鼠的急性中毒反应,初步评价其安全性。方法40只BALB/c小鼠(雌雄各半)随机分为4组,即10、20mg/kg给药组,空白质粒和生理盐水对照组,连续观察14d。结果各组动物无死亡,疫苗10mg/kg组未见明显毒性反应,疫苗20mg/kg组有个别动物出现短暂的活动减少,而空白质粒对照组出现活动减少和体重下降。结论日本血吸虫双价DNA疫苗对小鼠单次肌肉注射给药无明显毒性反应,预期临床应用安全性好。 Objective To investigate the acute toxicity of Schistosoma japonicum bivalent DNA vaccine. Methods Forty male and female BALB/c mice were randomly divided into 4 groups. The mice of low dose group were given each once only by iniection of muscle 10 mg/kg, ones of high dose group were given each in the same way with 20 mg/kg, and two control groups given each equivalent volume of 100 μl 0.9% NaCl and 100 μg pVIVO2. The investigation of 4 groups lasted 14 d. Indexes of hematology, weights coefficients of organs etc. were subjected to systematic examinations. Results There was no animal dead and there were no significant changes(P〉0.05) in hematology,weights coefficients of organs and pathological changes in all organs. Conclusions There are no abnormal changes in the acute toxicity trial with Schistosoma japonicum bivalent DNA vaccine, and bivalent DNA vaccine could be safe in clinical trial.
出处 《中国血吸虫病防治杂志》 CAS CSCD 2006年第6期416-418,共3页 Chinese Journal of Schistosomiasis Control
基金 国家高技术研究发展计划(863计划)(2004AA2Z3212)
关键词 日本血吸虫 双价DNA疫苗 毒性实验 单次剂量 Schistosoma japonicum Bivalent DNA vaccine Acute toxicity Single dosage
  • 相关文献

参考文献3

二级参考文献27

  • 1朱晓华,石佑恩,甘燕.日本血吸虫Sj14FABP与细胞因子IL-12重组质粒的构建和表达[J].中国人兽共患病杂志,2005,21(1):14-17. 被引量:5
  • 2甘燕,石佑恩,卜玲毅,宁长修,朱红刚.重组核酸疫苗诱导小鼠抗血吸虫感染的免疫学研究[J].中华医学杂志,2005,85(3):193-197. 被引量:10
  • 3[1]Waine GJ,McManus DP.Nucleic acids:Vaccines of the future [J].Parasitol Today,1995,11(3):113-116.
  • 4[3]Zhu Y, Ren J, Harn DA, et al. Protective immunity induced with 23 kDa membrane protein DNA vaccine of Schistosoma japonicum Chinese strain in infected C57 BL/6 mice [J]. Southeast Asian J Trop Med Public Health, 2003, 34(4):697-701.
  • 5[5]Fonseca CT, Brito CF, Alves JB, et al. IL-12 enhances protec tive immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway [J]. Vaccine, 2004,22(3-4): 503-510.
  • 6[6]Becker MM, Kalinna BH, Waine GJ, et al. Gene cloning, overproduction and purification of a functionally active cytoplasmic fatty acid-binding protein (Sj-FABPC) from the human blood fluke Schistosoma japonicum [J]. Gene, 1994 ,148(2):321-325.
  • 7[8]Skelly PJ, Shoemaker CB. Induction cues for tegument formation during the transformation of Schistosoma mansoni cercariae [J]. Int J Parasitol, 2000,30(5): 625-631.
  • 8[9]Varaldo PB, Leite LC, Dias WO, et al. Recombinant Mycobac terium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge [ J]. Infect Immun, 2004,72(6): 3336-3343.
  • 9Capron A,Riveau GJ,Bartley PB.et al.Prospects for a schistosome vaccine[J].Curr Drug Targets Immune Endocr Metabol Disord,2002,2:281-290.
  • 10Waine GJ,McManus DP.Schistosomiasis vaccine development the current picture[J].Bioessays,1997,19:435-443.

共引文献29

同被引文献23

  • 1侯俊玲,郑亚东,景志忠,才学鹏.DNA疫苗免疫佐剂的研究进展[J].中国兽医科技,2005,35(2):153-156. 被引量:5
  • 2范艳莹,吴长有.细胞因子直接诱导正常人CD4^+T细胞产生IL-17和IFN-γ[J].细胞与分子免疫学杂志,2007,23(10):914-916. 被引量:9
  • 3Namen A E, Lupton S, Hjerrild K, Wignall J, Mochizuki D Y, Schmierer A, Mosley B, March C J, Urdal D, Gillis S. Stimulation of B-cell progenitors by cloned murine interleukin-7. Narure, 1988, 333: 571- 573.
  • 4Jian Ming, Qingfu Zhang, Xueshan Qiu, Enhua Wang. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: A mechanism of lymphangiogenesis in lung cancer. European Journal of Cancer, 2009, 10, 1016.
  • 5Al-Rawi M A A, Watkins G, Mansel R E, Jiang W G. Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo. Britisb Journal of Surgery, 2005, 92: 305- 310.
  • 6Appasamy P M. Biological and clinical implications of interleukin-7 and lymphopoiesis. Cytokines Cellular Molecular Therapy, 1999, 5: 25- 39.
  • 7Kikuchi K, Kasai H, Watanabe A, Lai A Y, Kondo M. IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression. Immunology, 2008, 181(1): 383- 392.
  • 8Taguchi T, Takenouchi H, Shiozawa Y, Matsui J, Kitamura N, Miyagawa Y, Katagiri Y U, Takahashi T, Okita H, Fujimoto J, Kiyokawa N. Interleukin-7 contributes to human pro-B-cell development in a mouse stromal cell-depent culture system. Experimental Hematology, 2007, 35(9): 1398- 1470.
  • 9Yong Luo, Xiangping Kong, Aimin Xu, Shouguang Jin, Donghai Wu. Expression, purification, and functional characterization of recombinant human interleukin-7. Protein Expression and Purification, 2009, 63: 1- 4.
  • 10Wofford J A, Wieman H L, Jacobs S R, Zhao Y, Rathmell J C. IL-7 promotes Glutl trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood, 2008, 111(4): 2101- 2111.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部